Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

³­Ä¡¼º ¼Ò¾Æ °£Áú¿¡½Ã ÄÉÅ漺 ½ÄÀÌ¿ä¹ýÀÇ È¿°ú The Efficacy of Ketogenic Diet in Intractable Childhood Epilepsy

´ëÇÑ°£ÁúÇÐȸÁö 1998³â 2±Ç 2È£ p.127 ~ 133
±èÈﵿ,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÈﵿ ( Kim Heung-Dong ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¼Ò¾Æ°úÇб³½Ç

Abstract


Purpose : Ketogenic diet Is one of the effective anti-epileptic treatments for intractable childhood epilepsy. This study was performed to reveal the anti-epileptic efficacy, complication, tolerance, and other neurological effects of ketogenic diet.

Methods : Classic 4 : 1 ketogenic diet was introduced to 49 patients with intractable childhood epilepsy. Anti-epileptic efficacies were studied according to seizure classifications and epileptic syndromes, and other clinical features such as complications and tolerances were observed.

Results : Complete seizure control was observed in 78 patients (36.7%), and seizure reduction over 90% was obtained in 9 patients (18.4%). Ketogenic diet was most effective in infantile spasm with seizure free rate of 60%, and least effective in Lennox-Gastaut syndrome with seizure free rate of 26.7%. Improved cognitive function was noticed in 63.2% of patients, and improved behavior was seen in 27.8% of 18 patients with behavior disorder. Gastrointestinal complications such as vomiting and diarrhea was combined in 67.3%, controlled by symptomatic medications. Lipoid pneumonia was complicated in 4 patients, and prolonged increase of serum uric acid over 1 month was seen in 3 patients. Ketogenic diet was difficult to be maintained for a long duration especially in patients with incomplete seizure control.

Conclusion : Ketogenic diet was relatively safe and highly effective anti-epileptic treatment in many patients with intractable childhood epilepsy. Complete seizure reduction rate was highest in infantile spasm.

Å°¿öµå

°£Áú; ÄÉÅ漺 ½ÄÀÌ¿ä¹ý; ¿µ¾Æ ¿¬Ãà; Lennox-Gastaut ÁõÈıº
Epilepsy; Ketogenic diet; Intractable childhood epilepsy; Infantile spasm; Lennox-Gastaut syndrome; Complication

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS